investorscraft@gmail.com

Intrinsic ValueCreate SD Holdings Co., Ltd. (3148.T)

Previous Close¥3,245.00
Intrinsic Value
Upside potential
Previous Close
¥3,245.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Create SD Holdings Co., Ltd. operates as a diversified healthcare services provider in Japan, primarily focusing on drug retail, pharmacy dispensing, and nursing care. The company generates revenue through its extensive network of drugstores, which sell pharmaceuticals, cosmetics, food products, and daily necessities, catering to both general consumers and patients. Its vertically integrated model includes dispensing pharmacies, ensuring steady demand from prescription-based customers. Additionally, the company operates nursing homes and functional training centers, addressing Japan’s aging population needs. This dual focus on retail and care services positions Create SD Holdings as a resilient player in Japan’s healthcare sector, benefiting from demographic tailwinds and regulatory support for community-based care. The company’s competitive edge lies in its localized store presence, operational efficiency, and ability to cross-sell products across its retail and care segments. While facing competition from larger pharmacy chains and e-commerce players, its integrated approach and focus on underserved regional markets provide stability and growth potential.

Revenue Profitability And Efficiency

Create SD Holdings reported revenue of ¥422.3 billion for FY 2024, reflecting its strong market presence in Japan’s drug retail and care sectors. Net income stood at ¥13.7 billion, with diluted EPS of ¥215.6, indicating stable profitability. Operating cash flow of ¥21.0 billion underscores efficient working capital management, though capital expenditures of ¥16.2 billion suggest ongoing investments in store expansion and care facilities.

Earnings Power And Capital Efficiency

The company demonstrates consistent earnings power, supported by recurring revenue from pharmacy dispensing and care services. Its capital efficiency is evident in its ability to maintain profitability while expanding its store network. With minimal total debt (¥1 million) and robust cash reserves (¥38.2 billion), Create SD Holdings is well-positioned to fund growth initiatives without significant leverage.

Balance Sheet And Financial Health

Create SD Holdings maintains a strong balance sheet, with ¥38.2 billion in cash and equivalents and negligible debt, reflecting a conservative financial strategy. This low-leverage profile provides flexibility for strategic investments or acquisitions. The company’s asset-light model in retail and care services further supports its financial stability.

Growth Trends And Dividend Policy

The company benefits from structural growth drivers, including Japan’s aging population and increasing healthcare demand. Its dividend per share of ¥71 signals a commitment to shareholder returns, though payout ratios remain sustainable given its earnings and cash flow. Future growth may hinge on regional expansion and operational scaling in nursing care.

Valuation And Market Expectations

With a market cap of ¥202.2 billion and a beta of 0.34, Create SD Holdings is viewed as a defensive play in Japan’s healthcare sector. Its valuation reflects steady cash flows and low volatility, though growth expectations are tempered by the mature nature of its core markets.

Strategic Advantages And Outlook

Create SD Holdings’ integrated retail and care model provides resilience against economic cycles. Its focus on regional markets and aging demographics positions it for long-term growth, though competition and regulatory changes remain key risks. The company’s strong balance sheet and cash flow generation support continued investments in store optimization and care service expansion.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount